🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/06/1985 | 0,0212 USD |
| 28/02/1985 | 0,0212 USD |
| 03/12/1984 | 0,0212 USD |
| 31/08/1984 | 0,0199 USD |
| 29/05/1984 | 0,0199 USD |
| 01/03/1984 | 0,0199 USD |
| 29/11/1983 | 0,0199 USD |
| 29/08/1983 | 0,0186 USD |
| 31/05/1983 | 0,0186 USD |
| 28/02/1983 | 0,0186 USD |
| 30/11/1982 | 0,0186 USD |
| 30/08/1982 | 0,0186 USD |
| 01/06/1982 | 0,0186 USD |
| 01/03/1982 | 0,0186 USD |
| 01/12/1981 | 0,0186 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/11/2019 | 80,68 | 81,21 | 80,26 | 80,94 | +0,83% | 1,18% | 6.516.883 |
| 12/11/2019 | 79,75 | 80,94 | 79,75 | 80,27 | +1,01% | 1,48% | 8.616.656 |
| 11/11/2019 | 79,35 | 79,81 | 79,16 | 79,47 | -0,37% | 0,82% | 3.725.221 |
| 08/11/2019 | 79,11 | 79,88 | 78,92 | 79,76 | +0,86% | 1,21% | 6.653.123 |
| 07/11/2019 | 79,42 | 80,14 | 78,88 | 79,08 | -0,44% | 1,59% | 9.251.325 |
| 06/11/2019 | 79,73 | 80,11 | 79,32 | 79,44 | +0,40% | 0,99% | 9.735.606 |
| 05/11/2019 | 79,84 | 79,91 | 78,94 | 79,12 | -1,17% | 1,22% | 9.937.974 |
| 04/11/2019 | 81,67 | 81,77 | 80,04 | 80,06 | -1,22% | 2,13% | 8.947.195 |
| 01/11/2019 | 83,08 | 83,24 | 80,91 | 81,05 | -1,98% | 2,81% | 9.281.298 |
| 31/10/2019 | 82,16 | 83,01 | 81,59 | 82,69 | +0,51% | 1,72% | 12.419.429 |
| 30/10/2019 | 81,11 | 82,53 | 80,46 | 82,27 | +1,32% | 2,55% | 10.026.845 |
| 29/10/2019 | 80,20 | 81,84 | 78,91 | 81,20 | +3,53% | 3,65% | 17.371.019 |
| 28/10/2019 | 78,94 | 79,65 | 76,66 | 78,44 | -0,07% | 3,78% | 15.557.665 |
| 25/10/2019 | 78,50 | 79,06 | 78,27 | 78,49 | -0,39% | 1,00% | 7.868.384 |
| 24/10/2019 | 79,30 | 79,81 | 78,28 | 78,80 | -0,35% | 1,93% | 5.232.769 |
| 23/10/2019 | 77,57 | 79,07 | 77,44 | 79,07 | +1,93% | 2,10% | 8.511.961 |
| 22/10/2019 | 78,24 | 78,89 | 76,57 | 77,58 | -3,81% | 2,96% | 18.629.038 |
| 21/10/2019 | 81,08 | 81,16 | 80,23 | 80,65 | -0,19% | 1,15% | 5.352.136 |
| 18/10/2019 | 79,88 | 81,02 | 79,83 | 80,80 | +1,05% | 1,49% | 7.883.056 |
| 17/10/2019 | 80,55 | 80,77 | 79,90 | 79,96 | -0,77% | 1,08% | 7.178.486 |
| 16/10/2019 | 81,16 | 81,19 | 80,55 | 80,58 | -0,69% | 0,79% | 5.686.134 |
| 15/10/2019 | 81,01 | 81,20 | 80,72 | 81,15 | +0,41% | 0,60% | 5.205.102 |
| 14/10/2019 | 80,51 | 81,21 | 80,43 | 80,81 | +0,42% | 0,97% | 5.513.214 |
| 11/10/2019 | 80,44 | 81,53 | 80,40 | 80,48 | +0,69% | 1,40% | 6.229.626 |
| 10/10/2019 | 80,29 | 80,96 | 79,76 | 79,92 | -0,50% | 1,50% | 8.580.290 |
| 09/10/2019 | 80,31 | 80,62 | 79,70 | 80,32 | +1,07% | 1,14% | 4.660.875 |
| 08/10/2019 | 79,95 | 80,54 | 79,27 | 79,48 | -1,30% | 1,59% | 6.416.694 |
| 07/10/2019 | 81,14 | 81,21 | 80,11 | 80,52 | -0,72% | 1,36% | 5.086.154 |
| 04/10/2019 | 79,60 | 81,22 | 79,35 | 81,11 | +2,73% | 2,35% | 7.504.518 |
| 03/10/2019 | 78,18 | 79,08 | 77,89 | 78,95 | +1,37% | 1,53% | 5.790.095 |